0000899243-18-029744.txt : 20181128
0000899243-18-029744.hdr.sgml : 20181128
20181128164332
ACCESSION NUMBER: 0000899243-18-029744
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181126
FILED AS OF DATE: 20181128
DATE AS OF CHANGE: 20181128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Snodgres Jon
CENTRAL INDEX KEY: 0001613498
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 181206086
MAIL ADDRESS:
STREET 1: REPLIGEN CORPORATION, 41 SEYON STREET
STREET 2: BUILDING #1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02435
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-11-26
0
0000730272
REPLIGEN CORP
RGEN
0001613498
Snodgres Jon
C/O REPLIGEN CORPORATION
41 SEYON ST., BLDG 1, STE 100
WALTHAM
MA
02453
0
1
0
0
CFO
Common Stock
2018-11-26
4
M
0
11445
26.20
A
32344
D
Common Stock
2018-11-26
4
M
0
4000
24.50
A
36344
D
Common Stock
2018-11-26
4
M
0
6055
32.40
A
42399
D
Common Stock
2018-11-26
4
M
0
10253
26.05
A
52652
D
Common Stock
2018-11-26
4
S
0
31753
63.4874
D
20899
D
Stock Option (Right to Buy)
26.20
2018-11-26
4
M
0
11445
0.00
D
2025-02-26
Common Stock
11445
0
D
Stock Option (Right to Buy)
24.50
2018-11-26
4
M
0
4000
0.00
D
2024-07-14
Common Stock
4000
2000
D
Stock Option (Right to Buy)
32.40
2018-11-26
4
M
0
6055
0.00
D
2027-02-23
Common Stock
6055
12110
D
Stock Option (Right to Buy)
26.05
2018-11-26
4
M
0
10253
0.00
D
2026-02-26
Common Stock
10253
5127
D
Sale of common stock was effective pursuant to a 10(b)5-1 trading plan adopted on September 19, 2018.
$63.4874 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.18 to $64.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
This option is currently exercisable.
2,000 shares vest and become exercisable on each of the following dates: 7/14/2015, 7/14/2016, 7/14/2017, 7/14/2018 and 7/14/2019.
6,055 shares vest and become exercisable on each of the following dates: 2/23/2018, 2/23/2019 and 2/23/2020.
Shares vest and become exercisable as follows: 5,126 shares on 2/26/2017, 5,127 shares on 2/26/2018 and 5,127 shares on 2/26/2019.
/s/ Jeffrey P. Leduc (Attorney in Fact)
2018-11-28